EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Somatostatin receptor‐linked α‐particle therapy in neuroendocrine tumours

Shaunak Navalkissoor iD, Ashley Grossman iD

Journal of Neuroendocrinology · 2025-03 · 37 (3)

DOI: 10.1111/jne.13463 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 11.11.2024. Verfasst von Shaunak Navalkissoor und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Receptors, Somatostatin, Alpha Particles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence and prevalence of neuroendocrine tumours (NETs) are on the rise, but to date, only complete surgical resection is curative. Among the various therapeutic options for metastatic disease, peptide receptor radionuclide therapy (PRRT), linking a radioactive moiety to an octreotide derivative, has been shown to be highly efficacious and a well‐tolerated therapy, improving progression‐free survival and prolonging overall survival. Nevertheless, complete responses are rare, and the current β‐particle emitters have non‐optimal radiobiological properties. A new generation of α‐particle‐emitting radionuclides is being developed, with the advantages of very high energy and a short path length. We survey the most recent developments in this field, summarising the result of currently performed studies in this potentially ground‐breaking novel form of therapy for NETs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsReceptors, SomatostatinAlpha ParticlesHumansOctreotideAnimals

Stichwörter der Autor:innen

PRRTneuroendocrine tumoursradionuclidestherapyα‐particles

Substanzen

Receptors, SomatostatinOctreotide

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, London, UK.
  • NET UNIT, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, UK.

ORCID-Profile: Shaunak Navalkissoor, Ashley Grossman

Zitieren

APA

Navalkissoor, S., & Grossman, A. (2025). Somatostatin receptor‐linked α‐particle therapy in neuroendocrine tumours. Journal of Neuroendocrinology, 37(3). https://doi.org/10.1111/jne.13463

Vancouver

Navalkissoor S, Grossman A. Somatostatin receptor‐linked α‐particle therapy in neuroendocrine tumours. Journal of Neuroendocrinology. 2025;37(3). doi:10.1111/jne.13463

BibTeX
@article{Navalkissoor2025,
  author = {Navalkissoor, Shaunak and Grossman, Ashley},
  title = {Somatostatin receptor‐linked α‐particle therapy in neuroendocrine tumours},
  journal = {Journal of Neuroendocrinology},
  year = {2025},
  volume = {37},
  number = {3},
  doi = {10.1111/jne.13463}
}
Kostenlos starten →